FIND A DOCTOR
Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis.
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.
Δ9-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression in Vitro and in Vivo.
Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations.
Immunoactive effects of cannabinoids: Considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Endocannabinoids, feeding and suckling – from our perspective.
Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage.
The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol – studies in BV-2 microglia and encephalitogenic T cells
Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in Mice
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
Cannabinoid-based drugs as anti-inflammatory therapeutics
Cannabinoid CB2 receptors in human brain inflammation
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
Cannabinoids as novel anti-inflammatory drugs
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
Cannabinoids, inflammation, and fibrosis
Cannabinoids in models of chronic inflammatory conditions
Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability
Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation
Clinical Implications for Cannabinoid Use in the Rheumatic Diseases
Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
Activation of Cannabinoid CB2 ReceptoreMediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
Cannabidiol administration after hypoxiaeischemia to newborn rats reduces
long-term brain injury and restores neurobehavioral function
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury
Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia
HU-211, a Novel Noncompetitive N-Methyl-d-Aspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the Rat
Mechanisms of cannabidiol neuroprotection in hypoxiceischemic newborn pigs:
Role of 5HT1A and CB2 receptors
The Cannabinoid Agonist Win55212 Reduces Brain Damage in an In Vivo Model of Hypoxic-Ischemic Encephalopathy in Newborn Rats
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
Update on the Role of Cannabinoid Receptors after Ischemic Stroke